GO TO NEWSROOMeast
Ducommun Logo_RGB.jpg
Ducommun Incorporated to Hold Virtual 2020 Annual Shareholders Meeting
April 02, 2020 16:15 ET | Ducommun Incorporated
SANTA ANA, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Ducommun Incorporated (“Ducommun” or the “Company”) (NYSE:DCO) confirmed today that due to the rapidly evolving COVID-19 pandemic, and to...
Blue%20IB%20Logo%20-%20Small.jpg
INDEPENDENT BANK CORPORATION ANNOUNCES IT HAS ADDED TELECONFERENCE CAPABILITIES FOR ITS 2020 ANNUAL MEETING OF SHAREHOLDERS
April 02, 2020 16:15 ET | Independent Bank Corporation
GRAND RAPIDS, Mich., April 02, 2020 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that, due to...
ZUMIEZ INC. PROVIDES CORONAVIRUS RELATED BUSINESS UPDATE
April 02, 2020 16:05 ET | Zumiez Inc
LYNNWOOD, Wash., April 02, 2020 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) today provided a business update in response to the continued impact from novel coronavirus (COVID-19).  With the...
lumos.png
Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
April 02, 2020 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, April 02, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the promotion of...
monro.png
MONRO, INC. PROVIDES BUSINESS UPDATE AMID COVID-19 OUTBREAK
April 02, 2020 16:05 ET | Monro, Inc.
ROCHESTER, N.Y., April 02, 2020 (GLOBE NEWSWIRE) -- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today provided a business update for its fourth...
emergent logo.jpg
Emergent BioSolutions Partners with U.S. Government for Comprehensive Response to Expedite Development of Plasma-Derived Therapy for COVID-19
April 02, 2020 16:05 ET | Emergent BioSolutions
BARDA to provide $14.5 million in funding to support development of COVID-Human Immune Globulin (COVID-HIG), a human plasma-derived therapy candidate being developed as a potential treatment for...
HC2 Logo.jpg
HC2 CEO PHIL FALCONE SENDS LETTER TO STOCKHOLDERS
April 02, 2020 16:05 ET | HC2 Holdings, Inc.
NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, today issued the following letter from Phil Falcone, the...
Aehr Test Systems logo
Aehr Test Systems Reports 93% Revenue Growth Year over Year in Third Quarter
April 02, 2020 16:05 ET | Aehr Test Systems
FREMONT, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Fourth Quarter and Full Year 2019 Financial Results
April 02, 2020 16:02 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, April 02, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
EC-Logo-2018_TM_CMYK.jpg
electroCore Submits Emergency Use Authorization Application to Allow the Study and Use of gammaCore nVNS Therapy to Treat Respiratory Symptoms Associated with COVID-19
April 02, 2020 16:01 ET | electroCore, Inc.
BASKING RIDGE, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company has submitted an...